Showing results (371-380 of 554) with videos related to

Sort By:
Pageof 56
European Urology|April 22, 2023
PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) BluesNick Beije, Wassim Abida, Emmanuel S Antonarakis, et al.
The New England Journal of Medicine|May 4, 2023
Familial Clonal Hematopoiesis in a Long Telomere SyndromeEmily A DeBoy, Michael G Tassia, Kristen E Schratz, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
JCI Insight|August 29, 2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomesHannah E Bergom, Ella Boytim, Sean McSweeney, et al.
Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Genomic and Clinicopathologic Characterization of ATM-deficient Prostate CancerHarsimar Kaur, Daniela C Salles, Sanjana Murali, et al.
The Oncologist|January 24, 2013
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, David C Smith, et al.
The Prostate|August 2, 2017
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancerLauren C Harshman, Lillian Werner, Abhishek Tripathi, et al.
Journal of the National Cancer Institute|March 15, 2026
Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genesSiddhartha Yadav, Sonya Reid, Binyam Yilma, et al.
Molecular Imaging and Biology|April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Esther Mena, et al.
Pageof 56